NRG Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.nrgoncology.org
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
- Conditions
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
- Interventions
- Procedure: EsophagectomyRadiation: Intensity-Modulated Radiation TherapyRadiation: Proton Beam Radiation TherapyOther: Quality-of-Life AssessmentOther: Questionnaire AdministrationDrug: FOLFOX regimenDrug: CAPOX regimenDrug: 5FU
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 300
- Registration Number
- NCT03801876
- Locations
- 🇺🇸
Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
🇺🇸Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial
- Conditions
- Recurrent Prostate CarcinomaStage III Prostate Adenocarcinoma AJCC v7Stage IV Prostate Adenocarcinoma AJCC v7
- Interventions
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 324
- Registration Number
- NCT03371719
- Locations
- 🇺🇸
Arizona Center for Cancer Care - Gilbert, Gilbert, Arizona, United States
🇺🇸Arizona Center for Cancer Care-Peoria, Peoria, Arizona, United States
🇺🇸Arizona Center for Cancer Care - Scottsdale, Scottsdale, Arizona, United States
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
- Conditions
- Stage II Prostate Adenocarcinoma
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 698
- Registration Number
- NCT03367702
- Locations
- 🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸Lewis and Faye Manderson Cancer Center, Tuscaloosa, Alabama, United States
🇺🇸Arizona Center for Cancer Care - Gilbert, Gilbert, Arizona, United States
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
- Conditions
- Prostate AdenocarcinomaStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
- First Posted Date
- 2017-09-07
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 296
- Registration Number
- NCT03274687
- Locations
- 🇺🇸
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
- Conditions
- Stage IIA Breast CancerStage IIIA Breast CancerInvasive Breast CarcinomaStage II Breast CancerStage IIB Breast Cancer
- First Posted Date
- 2017-06-15
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 105
- Registration Number
- NCT03188393
- Locations
- 🇺🇸
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
🇺🇸Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
- Conditions
- Recurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v7Unresectable Hepatocellular Carcinoma
- First Posted Date
- 2017-06-14
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 186
- Registration Number
- NCT03186898
- Locations
- 🇺🇸
Emory Proton Therapy Center, Atlanta, Georgia, United States
🇺🇸Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
- Conditions
- Uterine Corpus CancerVaginal CarcinomaOvarian CarcinomaPostmenopausalVulvar CarcinomaBreast CarcinomaCervical Carcinoma
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 230
- Registration Number
- NCT03180294
- Locations
- 🇺🇸
Kaiser Permanente-Anaheim, Anaheim, California, United States
🇺🇸Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States
🇺🇸Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- Conditions
- Grade 2 MeningiomaIntracranial Meningioma
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 163
- Registration Number
- NCT03180268
- Locations
- 🇺🇸
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸Saint Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
🇺🇸Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
- Conditions
- GliomaAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic OligodendrogliomaDiffuse AstrocytomaOligoastrocytomaOligodendrogliomaWHO Grade 3 Glioma
- Interventions
- Procedure: Biospecimen CollectionOther: Laboratory Biomarker AnalysisRadiation: Intensity-Modulated Radiation TherapyProcedure: Magnetic Resonance ImagingRadiation: Proton Beam Radiation TherapyOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 120
- Registration Number
- NCT03180502
- Locations
- 🇺🇸
MaineHealth Maine Medical Center- Scarborough, Scarborough, Maine, United States
🇺🇸University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸Boca Raton Regional Hospital, Boca Raton, Florida, United States
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
- Conditions
- Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
- Interventions
- Radiation: 3-Dimensional Conformal Radiation Therapy (3D-CRT)Radiation: Intensity-Modulated Radiation Therapy (IMRT)Radiation: Stereotactic Body Radiation Therapy (SBRT)
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 218
- Registration Number
- NCT03137771
- Locations
- 🇺🇸
Arizona Center for Cancer Care - Gilbert, Gilbert, Arizona, United States
🇺🇸Arizona Center for Cancer Care - Scottsdale, Scottsdale, Arizona, United States
🇺🇸Los Angeles General Medical Center, Los Angeles, California, United States